RxDoctor Payments Data

Walter Strash, DPM

Foot & Ankle Surgery · San Antonio, TXNPI 1528117140

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,100 of the $85,849 with a category attached, or 63.0%. 38 manufacturers reported payments, led by Sequence Lifescience, Inc at 34.9% of the total. Reporting peaked in 2024 at $56,287 and has fallen 83.4% since, to $9,349 in 2025. Among foot & ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,849in general payments, 2019–2025

Across 161 payments — averaging $533.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sequence Lifescience, Inc$30K
  • Nvision Biomedical Technologies, Inc.$21K
  • Convatec Inc.$20K
  • Endo USA, Inc.$8K
  • Medinc Of Texas$2K
  • Stryker$1K
  • plus $3K from 32 others

What the payments were for

  • Royalty or licence$1,5202%
  • Consulting fees$54,10063%
  • Speaking & faculty fees$2,2503%
  • Travel & lodging$2930%
  • Food & beverage$4,8046%
  • Education$2,8833%
  • Other$20,00023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$85,849 in reported general payments places this provider in the 95th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$172,362
Medicare patients
494
Services billed
3,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox83$1,953
Terbinafine Hcl138$903
Cephalexin53$503
Ammonium Lactate16$279
Naproxen48$248

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →